<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">60</article-id>
      <article-categories>
        <subj-group>
          <subject>Original article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pharmacological Tests for Horner Syndrome Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Skorkovská</surname>
            <given-names>Karolina</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>30</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <issue>2</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>The case report presents a patient, who was examined at our department due to anisocoria that was present for more than one year. Besides the anisocoria the patient had no other pathological symptoms. The pupil on the right eye was larger than on the left eye by more than 1mm. Photoreaction was present on both eyes with a dilatation deficit on the left eye. There was also a slight ptosis on the left. The anterior and posterior eye segment was normal, only the iris of the left eye was slightly decoloured. The ophthalmological finding was pointing to Horner syndrome on the left side. The cause of the syndrome was not found. The case report discusses current problems of pharmacological pupillary tests used in Horner syndrome. Alternatives to the standard cocaine test are proposed, with respect to substances currently available in the Cz ech Republic.</p>
      </abstract>
      <kwd-group>
        <kwd>anisocoria</kwd>
        <kwd>Horner syndrome</kwd>
        <kwd>cocaine test</kwd>
        <kwd>phenylephrine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R9371">
        <mixed-citation>Cooper-Knock, J., Pepper, I., Hodgson, T. et al.: Early diagnosis of Horner syndrome using topical apraclinidine. J Neuro-Ophthalmol, 31, 2011: 214–216.</mixed-citation>
      </ref>
      <ref id="R9372">
        <mixed-citation>Davagnanam, I., Fraser, CL., Miszkiel, K. et al.: Adult Horner´s syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye, 27, 2013: 291–298.</mixed-citation>
      </ref>
      <ref id="R9373">
        <mixed-citation>Danesh-Meyer, HV., Savino, P., Sergott, R.: The correlation of phenylephrine 1% with hydroxyaphetamine 1% in Horner´s syndrome. Br J Ophthalmol, 88, 2004, 4: 592–593</mixed-citation>
      </ref>
      <ref id="R9374">
        <mixed-citation>Dewan, MA., Harrison, AR., Lee, MS.: False-negative apraclonidine testing in acute Horner syndrome. Can J Ophthalmol, 44, 2009: 109–110. ophthalmology. Philadelphia, Lippincott Williams&amp;Wilkins, 2004, s. 660.</mixed-citation>
      </ref>
      <ref id="R9375">
        <mixed-citation>Falzon, K., Jungkim, S., Charalampidou, S. et al.: Denervation supersensitivity to 1% phenylephrine in Horner syndrome can be demonstrated 10 days after the onset of symptoms. Br J Ophthalmol, 93, 2009: 130.</mixed-citation>
      </ref>
      <ref id="R9376">
        <mixed-citation>Freedman, KA., Brown, SM.: Topical apraclonidine in the diagnosis of suspected Horner syndrome, J Neuroophthalmol, 25, 2005: 83–5.</mixed-citation>
      </ref>
      <ref id="R9377">
        <mixed-citation>Kawasaki, A., Borruat, F X.: False negative apraclonidine test in two patients with Horner syndrome. Klin Monatsbl Augenheilkd, 225, 2008: 520–522.</mixed-citation>
      </ref>
      <ref id="R9378">
        <mixed-citation>Miller, N.: The autonomic nervous system. In Miller, NR., Newman, NJ. (Eds), Walsh and Hoyt´s clinical neuro-</mixed-citation>
      </ref>
      <ref id="R9379">
        <mixed-citation>Mughal, M., Longmuir, R.: Current pharmacologic testing for Horner syn- drome. Current Neurology and Neuros- cience Reports, 9, 2009: 384–389.</mixed-citation>
      </ref>
      <ref id="R9380">
        <mixed-citation>Otradovec, J.: Zornice. In Otradovec, J. (Ed), Klinická neurooftalmologie. Praha, Grada Publishing, 2003, s. 142–154.</mixed-citation>
      </ref>
      <ref id="R9381">
        <mixed-citation>Wilhelm, H., Wilhelm, B.: Diagnostik von Pupillenstörungen. In Schiefer, U., Wilhelm, H., Zrenner, E., Burk, A. (Eds), Praktische Neuroophthalmologie. Heidelberg, Kaden Verlag, 2003, s. 53–66.</mixed-citation>
      </ref>
      <ref id="R9382">
        <mixed-citation>Wilhelm, H., Tonagel, F ., Heine, C.: Was tun bei Horner-Syndrom? Z prakt Augenheilkd, 35, 2014, 3: 119. in the case of suspicion of Horner syndrome to perform a test with 1% phenylephrine solution or 1% adrenaline. If Horner syndrome is confirmed, in the Czech Republic patients are most often sent from the ophthalmological centre to a neurologist, who should attempt to detect the possible cause of Horner syndrome on the basis of the anamnesis and accompanying symptoms, and according to this indicate further examinations, most com-</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
